Summary
Melissa Wickremasinghe is the Trust Lead for Interstitial Lung diseases and Sarcoidosis at Imperial College Healthcare NHS trust.
Publications
Journals
Keir GJ, Maher TM, Ming D, et al. , 2014, Rituximab in severe, treatment-refractory interstitial lung disease, Respirology, Vol:19, ISSN:1323-7799, Pages:353-359
Saketkoo LA, Mittoo S, Frankel S, et al. , 2014, Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases, The Journal of Rheumatology, Vol:41, ISSN:0315-162X, Pages:792-798
Saketkoo LA, Mittoo S, Huscher D, et al. , 2013, Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials, Thorax, Vol:69, ISSN:0040-6376, Pages:428-436
Singanayagam A, Manalan K, Sridhar S, et al. , 2013, Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-alpha antagonist therapy, Thorax, Vol:68, ISSN:0040-6376, Pages:955-961
Thillai M, Potiphar L, Eberhardt C, et al. , 2012, Obstructive lung function in sarcoidosis may be missed, especially in older white patients, European Respiratory Journal, Vol:39, ISSN:0903-1936, Pages:775-777